-

SHAREHOLDER ALERT: Robbins LLP Reminds Investors That The Honest Company, Inc. (HNST) is Being Sued for Misleading Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired The Honest Company, Inc. (NASDAQ: HNST) common stock in connection with the Company's May 2021 initial public offering ("IPO"). The complaint pursues claims under the Securities Act of 1933. Honest claims to be a "digitally-native, mission-driven brand focused on leading the clean lifestyle movement, creating a community for conscious consumers and seeking to disrupt multiple consumer product categories.”

If you suffered a loss due to The Honest Company, Inc.'s misconduct, click here.

The Honest Company, Inc. (HNST) Misled the Investing Public Regarding Product Demand

According to the complaint, the registration statement and prospectus filed in connection with the Company's IPO were materially false and misleading. Specifically, defendants omitted that prior to the IPO, the Company's financial results had been significantly impacted by a multimillion-dollar COVID-19 stock-up for products in its Diapers and Wipes and Household and Wellness categories and that at the time of the IPO, the Company was experiencing decelerating demand for such products.

On August 13, 2021, just three months after the IPO, Honest issued its second quarter 2021 financial results, reporting a net loss of $20 million for the second quarter of 2021, compared to a net loss of only $0.4 million for the second quarter of 2020. Honest disclosed that its revenue grew only 3% as compared to the second quarter of 2020 because it was negatively impacted by "an estimated $3.7 million COVID-19 stock-up impact primarily in Diapers and Wipes in the prior year period." The Diapers and Wipes category experienced a revenue decline of 2% compared to the same quarter in 2020, and the Household and Wellness category experienced a revenue decline of 6% from the same quarter in 2020 "as consumer and customer demand for sanitization products decreased as consumers became vaccinated and customers managed heavy levels of inventory."

On this news, the Company's stock fell almost $4.00 per share, or 28%, to close at $10.07 per share on August 13, 2021. The stock currently trades around $9.37, significantly less than its $16.00 IPO price.

If you purchased shares of The Honest Company, Inc. (HNST) pursuant to the Company's IPO, you have until November 15, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against The Honest Company, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:HNST

Release Summary
SHAREHOLDER ALERT: Robbins LLP Reminds Investors That The Honest Company, Inc. (HNST) is Being Sued for Misleading Shareholders
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Stockholder Notice: Robbins LLP Informs Investors of the Atara Biotherapeutics, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Atara Biotherapeutics, Inc. (NASDAQ: ATRA) securities between May 20, 2024 and January 9, 2026. Atara develops therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases in the U.S. and the United Kingdom (“U.K.”). The Company’s lead product candidate is tabelecleucel (also referred to as tab-cel or EBVALLO), a T-ce...

Stockholder Notice: Robbins LLP Informs Investors of the Coty Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Coty Inc. (NYSE: COTY) common stock between November 5, 2025 and February 4, 2026. Coty together with its subsidiaries, manufactures, markets, distributes, and sells branded beauty products worldwide. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Inves...

Investor Notice: Robbins LLP Informs Investors of the Lufax Holding Ltd. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Lufax Holding Ltd. (NYSE: LU) securities between April 7, 2023 and January 26, 2025. Lufax Holding Ltd engages in the retail credit and enablement business to borrowers and institutions in China. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigat...
Back to Newsroom